Alarming Antimicrobial Prescribing Patterns at a Tertiary Hospital in Nigeria: A Point Prevalence Survey using the Global-PPS Protocol

Main Article Content

M. Z. Sabitu
Y. Mohammed
O. O. Oduyebo
I. N. Nwafia
T. Yusuf
F. B. Jiya
I. W. Musa
B. G. Aljannare
J. Abubakar
B. Makun
Y. Saminu
M. K. Dada
A. Abdulmalik
H. Mathew
A. Versporten
U. Faruk

Keywords

Antimicrobial resistance, antimicrobial stewardship, Point prevalence survey, AWaRe classification, Nigeria

Abstract

Background: Antimicrobial resistance is a critical threat in Nigeria, where inappropriate prescribing remains one of the major drivers. This study evaluated antimicrobial use patterns at Usmanu Danfodiyo University Teaching Hospital (UDUTH) using the Global Point Prevalence Survey methodology.


Methodology: A cross-sectional survey was conducted October 21-25, 2024 across all inpatient wards using standardized GPPS protocols. Data collectors received virtual training through the Fleming Fund project. All patients admitted before 8:00 AM on survey days were included, with data collected on antimicrobial prescriptions, indications, and quality indicators.


Results: A total of 262 inpatients were surveyed, with 195 prescribed antimicrobials, yielding a high overall prevalence of 74.4%. Ward-specific analysis revealed statistically significant variation: Neonatal wards had universal use (23/23, 100%; p<0.001), significantly higher than Adult Medical (50/79, 63.2%; p<0.001) and Paediatric Surgical (24/39, 61.5%; p=0.002) wards. Paediatric Medical ward use (33/36, 91.7%; p<0.001) was also significantly higher. The high rates in Adult Surgical (44/53, 83.0%) and Adult Intensive Care (15/18, 83.3%) wards were not statistically significant (p>0.05) from the hospital average. A total of 437 antimicrobial agents were prescribed which was dominated by antibacterials (310/437, 71.0%), primarily third-generation cephalosporins (83/310, 26.9%). Empiric therapy accounted for 85.7% of treatments. Critical documentation gaps and low guideline compliance (medical: 11.5%; surgical: 1.6%) were observed. AWaRe classification showed 61.0% Watch antibiotic use, and 37.5% (164/437) of prescribed doses were missed, primarily due to patients inability to afford (120/164, 73.2%)


Conclusion: UDUTH exhibits excessive antimicrobial use with significant, non-random inter-ward variation, dominated by broad-spectrum agents and poor prescribing quality. These findings stress an urgent need for targeted antimicrobial stewardship programs, strengthen diagnostic infrastructures, and policies to ensure affordable access.


 

Abstract 40 | PDF Downloads 12 EPUB Downloads 14

References

1. Ahmed SK, Hussein S, Qurbani K, Ibrahim RH, Fareeq A, Mahmud KA, et al. Antimicrobial resistance: Impacts, challenges, and future prospects. Journal of Medicine, Surgery, and Public Health. 2024; 2: 1-9. 100081. https://doi.org/10.1016/j.glmedi.2024.100081
2. Maqaji A, Mahmud Z, Kwarau NL, Abdullahi M, Zamo AB, Bello T, et al. Antimicrobial resistance in Northern Nigeria: A growing public health threat. Journal of Pure and Applied Sciences. 2025; 25(2): 125-137. https://www.researchgate.net/publication/394230052
3. Nigeria Centre for Disease Control and Prevention. "Nigeria Joins the Global Community to Commemorate World Antimicrobial Awareness Week (WAAW)." NCDC, 19 Nov. 2023, ncdc.gov.ng/news/504/nigeria-joins-the-global-community-to-commemorate-world-antimicrobial-awareness-week-(waaw). Accessed 2 Sept. 2025.
4. Alabi ED, Rabiu AG, Adesoji AT. A review of antimicrobial resistance challenges in Nigeria: The need for a one health approach. One Health. 2025; 20: 101053.
doi: 10.1016/j.onehlt.2025.101053. PMID: 40370425; PMCID: PMC12077226.
5. Oyekale OT, Ojo BO, Oguntunmbj DE, Oyekale OI. Prevalence and risk factors for methicillin-resistant Staphylococcus aureus carriage among healthcare workers in a tertiary health facility in Nigeria. Journal of Advances in Medicine and Medical Research, 2021; 33(16): 43–52. https://doi.org/10.9734/JAMMR/2021/v33i1631000
6. Goossens H, & Nathwani D. Global point prevalence survey of antimicrobial consumption and resistance (2019 GLOBAL-PPS): Protocol. Global-PPS. 2019; https://www.global-pps.com/wp-content/uploads/2019/01/Global-PPS-2019-protocol.pdf.
7. Oduyebo OO, Olayinka AT, Iregbu KC, Versporten A, Goossens H, Nwajibu-Princewill PF, et al. A point prevalence survey of antimicrobial prescribing in four Nigerian Tertiary Hospitals. Ann Trop Pathol. 2017; 8(1): 42–46. https://doi.org/10.4103/atp.atp_38_17
8. BioVentures for Global Health. Usmanu Danfodiyo University Teaching Hospital [Internet]. [cited 2025 Sep 2]. Available from: https://bvgh.org/usmanu-danfodiyo-university-teaching-hospital/
9. Wikipedia. Usmanu Danfodiyo University Teaching Hospital [Internet]. 2022 Jun 22 [cited 2025 Sep 2]. Available from: https://en.wikipedia.org/wiki/Usmanu_Danfodiyo_University_Teaching_Hospital
10. Usmanu Danfodiyo University Teaching Hospital. About Usmanu Danfodiyo Teaching Hospital (UDUTH) [Internet]. [cited 2025 Sep 2]. Available from: https://www.uduth.org.ng/index.php?p=About
11. Egbuchulam N, Anyika EN, Soremekun RO, Oduyebo OO, Mabogunje CA, Animasahun BA, et al. A point prevalence survey of antibiotic prescribing in three Nigerian public children’s hospitals. Nigerian Journal of Pharmacy. 2023; 57(1): 478–490. https://doi.org/10.51412/psmip.2023.9
12. Adeyemo AT, Odeyemi AO, Adeyemo AT, Oladele AO, Olagunju FA, Adeyeye AG, et al. A point prevalence survey of antimicrobial use among hospitalized patients in UNIOSUN Teaching Hospital, Osogbo. Pan African Journal of Life Sciences. 2025; 9(2): 433–440.
13. Moja L, Zanichelli V, Mertz D, Gandra S, Cappello B, Cooke GS, et al. WHO’s essential medicines and AWaRe: Recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections. Clin Microbiol Infect. 2024;30(Suppl 1):S1–51. doi:10.1016/j.cmi.2024.02.003
14. Uqbo EN, Kotey FCN, Donkor ES. Antibiotic resistance genes circulating in Nigeria: a systematic review and meta-analysis from the One Health perspective. BMC Medical Genomics. 2025; 18(1): 113. https://doi.org/10.1186/s12920-025-02163-y.
15. Nwafia IN, Nwachukwu PT, Orakwe O, Ebede SO, Amagwu C, Aroh A, et al. Point prevalence survey of antimicrobial prescription and consumption in a Nigerian tertiary hospital: A gateway to the antimicrobial stewardship program. Nigerian Journal of Clinical Practice. 2024; 27(6): 702–707. https://doi.org/10.4103/njcp.njcp_449_23.
16. Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrobial Resistance and Infection Control, 2017; 6(1): 47. https://doi.org/10.1186/s13756-017-0208-x.
17. Olayinka, AT, Jimoh O, Ejembi J, Ige OT, Lamido Z, Ibrahim A, et al. Antimicrobial prescription pattern in a tertiary hospital. Sahel Medical Journal, 2020; 23(2): 103–108. https://doi.org/10.4103/smj.smj_17_18.
18. Awulu OA, Jenkins A, Balogun BA, Chukwu EE, Fasina FO, Egwuenu A, et al. Prioritising intervention areas for antimicrobial resistance in Nigeria’s human and animal health sectors using a mixed-methods approach. One Health. 2025; 20: 101082. https://doi.org/10.1016/j.onehlt.2025.101082.
19. Iheanacho CO, Eze UIH. A systematic review of in-patients’ antimicrobial prescriptions and status of antimicrobial stewardship programmes in Nigerian hospitals. Future Journal of Pharmaceutical Sciences, 2021; 7(1): 216. https://doi.org/10.1186/s43094-021-00365-6
20. Federal Ministries of Agriculture and Food Security; Environment; and Health and Social Welfare. (2024). One Health Antimicrobial Resistance National Action Plan 2.0 (2024–2028). Federal Republic of Nigeria.
21. Isezuo KO, Abubakar J, Mohammed Y, Sani UM, Waziri UM, Garba BI, et al. Antimicrobial susceptibility pattern of pharyngeal isolates of children seen in a tertiary facility in Sokoto over three years (2022-2024). Nigerian Medical Journal. 2025; 66(2): 586–597. https://doi.org/10.71480/nmj.v66i2.717
22. Alabi ED, Rabiu AG, Adesoji AT. A review of antimicrobial resistance challenges in Nigeria: The need for a one health approach. One Health. 2025; 20: 101053. https://doi.org/10.1016/j.onehlt.2025.101053.